Insite

Leave a Comment / By /
  • BC-CfE’s research laboratory produced techniques to measure the amount and impact of different levels of adherence to HIV therapies.
  • BC-CfE initiates the Scientific Evaluation of North America’s first supervised injection facility – Insite.
  • BC-CfE initiates a large cohort study of street-involved youth to examine their health-related needs.

Leave a Reply

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search